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Abstract
Objectives: This study sought to explore the epidemiological association between the exclusive use and the combined 
use of snuff and smoking on the prevalence of osteoporosis in a national population sample of South African women 
who were 40 years and older.
Materials and Methods: This study involved a nationally representative sample of South African women who were 
40 years and older and took part in the 2003/2004 South African Demographic and Health Survey (n = 2050). Data on 
tobacco use patterns, dietary calcium intake and other relevant factors were obtained through an interviewer-administered 
questionnaire. As part of the data collection procedure, participants were asked whether a doctor, a nurse or any other 
health professional had ever told them they had osteoporosis. Those who answered in the affirmative and/or presented 
medications for osteoporosis were regarded as having osteoporosis.
Results: The prevalence of osteoporosis was higher among those who had ever used both snuff and 
smoked (17.2%) either in the past or currently than among those who had ever used snuff only (5%) or smoked 
only (5.1%). Even after controlling for potential confounders in a multivariable-adjusted logistic regression, 
the combined use of snuff and smoking remained positively associated with osteoporosis (odds ratio = 3.60, 
95% confidence interval: 1.03-12.61). However, higher dietary calcium intake was negatively associated with 
osteoporosis.
Conclusions: Based on these findings, it can be concluded that the combined lifetime use of both snuff and cigarettes 
may increase the odds of developing osteoporosis among women who are 40 years and older.
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Osteoporosis is most common among postmenopausal 
women. It is associated with significant morbidity and 
even mortality.[1] In addition to the known risk factors 
for osteoporosis,[2] a number of studies have associated 
exposure to tobacco smoke, including second‑hand smoke, 
with low bone mineral density and thus increased risk for 
osteoporosis.[3,4] However, a recent review suggests that 
the evidence on the role of smoking on low bone mass 
density remains inconclusive.[2] One study in the US has 
demonstrated smokeless tobacco or snuff use as a risk for 
osteoporosis, with a stronger effect demonstrated among 
former snuff users than among current snuff users.[1]
The association between tobacco use and osteoporosis has 
been partly attributed to the effect of nicotine.[3] Nicotine 
has been suggested to have an anti‑estrogenic effect, 
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especially in females, which could lead to early menopause 
and osteoporosis in smokers.[3]
Despite the fact that snuff use is more common than 
smoking in the majority of women in the South African 
population (notably among black African women)[5] and 
that the nicotine delivery capacity of common snuff products 
in South Africa has been reported to be relatively higher 
than that of most commercial brands elsewhere,[6] no prior 
study has investigated the role of snuff use as a risk to bone 
health in this population. Considering the recent promotion 
of smokeless tobacco use in both high‑income and low and 
middle income countries (including in Nigeria and South 
Africa) as a safer alternative to smoking tobacco or as an 
aid to smoking cessation[7] and the potential for such a 
strategy to result in dual use of snuff and cigarettes,[8] the 
present study sought to explore the association between the 
exclusive use and combined use of smoked and smokeless 
tobacco products on the prevalence of osteoporosis in a 
national population sample of South African women who 
were aged 40 years and older.
Materials and Methods
Data source and study design
Data for this study were obtained from women who were 
40 years and older (n = 2,050) and who participated in the 
South African Demographic and Health Survey (SADHS 
2003)[9] conducted between October 2003 and August 2004. 
The details of the sampling procedure used in the SADHS 
have been previously published.[5] Briefly, SADHS 2003 
was a nationally representative, cross‑sectional household 
survey. It used a stratified, two‑staged, probability sample 
design. The first stage involved selecting census enumerating 
areas as the primary sampling units, with a probability 
proportional to size, based on the number of households 
in the enumeration areas. The second stage involved 
a systematic sampling of households from the selected 
enumeration areas. The data consist of 10 strata, one for 
each of the nine provinces, with 1,000 households allocated 
to each stratum. An additional stratum was selected in order 
to cover sample areas with predominantly Indian/Asian 
households because of the small percentage (≤3%) of this 
group in the South African population.
Data collection procedure and measures
Trained fieldworkers administered the questionnaires, which 
were prepared in all of South Africa’s 11 official languages. 
A self‑rated general health assessment of respondents was 
done by asking the following question: “Would you say 
your health is poor, average, good or very good/excellent?” 
Consistent with the World Health Organization step wise 
approach to chronic disease risk factor surveillance,[10] the 
study participants were also asked whether a doctor or nurse 
or any other kind of health worker had ever told them they 
had osteoporosis. Those who answered “yes” and/or presented 
their medication for osteoporosis when asked about any use of 
medication were categorized as having osteoporosis. The body 
mass index was calculated based on a duplicate measurement 
of the height and weight of each of the study participants.
The respondents who claimed that they currently smoked 
daily were asked about the number of cigarettes they smoked 
daily. Similarly, those who indicated that they currently 
used snuff daily were also asked about the frequency of their 
daily use of snuff. The study participants were then asked 
whether in the past, they had smoked daily and had used 
any snuff products. Those who responded in the affirmative 
to their current and past use of either tobacco products were 
classified as “ever users.”
Considering the well‑established relationship between 
osteoporosis and body calcium,[11] calcium and other 
micronutrient intake was assessed by means of a 30‑item 
food frequency questionnaire as part of the nutritional index 
developed for South Africa.[12] Each of the participants’ asset 
index, which was computed based on principal component 
analysis of the responses to questions on ownership of 
certain household items, was used to assess socio‑economic 
status (Cronbach alpha = 0.73). In particular, the survey 
respondents were asked whether they had any of the following 
household items in a working condition: A radio, television, 
computer, refrigerator, landline telephone and/or a cell‑phone. 
Those who answered in the affirmative were scored as “1.” 
Otherwise, a “0” was assigned. The total scores were auto 
ranked into three socio‑economic categories, namely those in 
the lowest, middle and highest tertiles. The respondents were 
also asked to indicate the highest level of education completed.
Data analysis
In order to account for selection probabilities and the complex 
sample design used in the SADHS 2003, weight adjustments 
were made and the data analysis was performed in a survey 
mode using the “svy” command in STATA version 10 (Stata 
Corporation, College Station, Texas, USA). Descriptive 
statistics were carried out to summarize the data as prevalence 
rates (%). Multiple logistic regression was performed to 
determine the independent association between “ever 
tobacco use” (exclusive and combined) and osteoporosis after 
controlling for potential confounders such as participants’ 
socio‑economic status and calcium intake. The estimated 
daily dietary calcium intake was a continuous variable with 
a non‑normal distribution; hence, it was log‑transformed to 
approximate normality. All statistical analysis was two‑tailed 
and the level of significance was set at P < 0.05.
Results
Of the study respondents, 67.2% (n = 1269) had never 
used any form of tobacco, 15.7% (n = 320) had used only 
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snuff, 15.1% (n = 346) had smoked cigarettes only and 
2% (n = 35) had both smoked cigarettes and used snuff in 
the past or were doing so at the time of the survey.
Among all the respondents who had ever used tobacco, the 
prevalence of osteoporosis was highest among those who 
had ever used snuff and smoked. The mean frequency of 
the daily use of smokeless tobacco was 5.1 (95% confidence 
interval [CI]: 4.6‑5.6) while the average number of 
cigarettes smoked per day was 6.2 (95% CI: 5.4‑7.1). The 
prevalence of osteoporosis was the highest among Whites, 
those who did not complete high school and those in the 
highest socio‑economic class tertile [Table 1].
Compared to never tobacco users, only the ever use of both 
snuff and cigarette smoking in the past or currently was 
significantly associated with osteoporosis (odds ratio (OR) 
=3.60, 95% CI: 1.03‑12.61) [Table 2].
Higher daily dietary calcium intake was negatively associated 
with osteoporosis (OR = 0.75; 95% CI: 0.59‑0.95). 
Furthermore, compared with the respondents who 
self‑reported poor general health, those who self‑reported 
that they had good or excellent health were less likely to 
have osteoporosis.
Discussion
This study demonstrated a strong association between ever 
use of both snuff and cigarette smoking and osteoporosis, 
but no significant association was observed between the 
ever exclusive use of either form of tobacco. We found that 
the higher the daily dietary intake of calcium, the lower the 
odds of reporting osteoporosis.
Similar to a previous observation of higher odds of 
osteoporosis among former tobacco users, as opposed 
to current users,[1] the intensity of the current use of 
either product was not associated with the prevalence of 
osteoporosis, even though the frequency of current snuff use 
tended to be associated with higher odds of osteoporosis. 
The reason why ever use and not intensity of current use 
was associated with osteoporosis might be that users try 
to reduce the amount of tobacco used or altogether quit 
the use of tobacco when osteoporosis or any other medical 
condition develops. Conceivably, combined use increases 
the cumulative levels of nicotine in the blood, given that 
snuff delivers a higher amount of nicotine from a single 
dose than cigarette smoking does.[6,13] It was therefore not 
surprising that increased snuff frequency as opposed to 
increased cigarettes smoked per day tended to be associated 
with higher odds of osteoporosis. This observation also 
Table 2: Multiple logistic model for factors associated 
with osteoporosis
Characteristics Odds ratio 95% confidence 
interval
Ever tobacco use
Never used tobacco 1.0
Ever used only snuff 0.52 0.22-1.23
Ever smoked only 1.49 0.60-3.69







Less than high school 1.0
High school 0.13 0.03-0.58








Dietary calcium intake (Log) 0.75 0.59-0.95
Daily frequency of current snuff use 1.10 1.00-1.21
Cigarettes currently smoked per day 0.88 0.77-1.01
Table 1: Prevalence of osteoporosis relative to 
socio-demographic characteristics and tobacco use
Characteristics % Osteoporosis (n) P value
Ever tobacco use
Never used tobacco 4.90 (n=61) 0.07
Ever used only snuff 5.00 (n=22)
Ever smoked only 5.10 (n=17)
Ever smoked and used snuff 17.20 (n=5)
Race





Less than high school 5.60 (n=98) 0.24
High school 1.90 (n=5)
More than high school 3.39 (n=2)
Asset index




Not good 5.80 (n=91) 0.09
Good/excellent 3.03 (n=11)
Body mass index
Underweight 5.37 (n=6) 0.97
Normal weight 5.11 (n=30)
Overweight 4.92 (n=28)
Obese 5.57 (n=36)
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supports a previous observation that osteoporosis was 
associated mainly with heavy smoking, but had no significant 
association with either moderate or light smoking,[3] as is 
commonly the case in the studied population.
Although snuff use is most common among black Africans, 
uneducated and rural South African women,[14] it was 
among the White and the most educated women that a 
higher proportion of smokers was found that tend to smoke 
more intensively and that had the highest prevalence of 
osteoporosis. This observation suggests that that raised 
blood nicotine may not be the only factor explaining higher 
prevalence of osteoporosis in tobacco users. Other factors 
may include genetic predisposition[15] and other factors not 
controlled for in the current study.
Study limitations
This is a cross‑sectional study and does not establish 
causality, as there was no record of the temporal order 
of events. Furthermore, the current study relied on 
self‑reported tobacco use and osteoporosis and thus it 
was subject to reporting bias. For instance, it is possible 
that current smokers with osteoporosis may find it socially 
desirable to under‑report the intensity of their smoking. 
However, considering that other potential under‑reporting 
would probably occur randomly (that is, would not be 
related to tobacco use status), this self‑reporting is not likely 
to influence the results of our analysis on the association 
between tobacco use and osteoporosis significantly. 
Another limitation of this study is that the dataset used is 
dated. The SADHS 2003 is the most recent demographic 
and health survey made publicly available and also since 
osteoporosis is a biological process, the results are not likely 
to be affected.
Despite these limitations, this study provides information 
on the factors associated with osteoporosis using a large 
nationally representative population sample from a 
developing country.
Conclusion
This study’s findings suggest that combined users of both 
snuff and cigarette in South Africa may carry a higher risk of 
osteoporosis. The findings from this study highlight the need 
for tobacco use prevention and for health‑care professionals 
to advise their patients on the importance of cessation of 
all forms of tobacco use in the prevention of osteoporosis. 
This is an important message, especially because snuff users 
in South Africa are predominantly women.
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